Excellence in Dermatology™
Excellence in Dermatologic Surgery™
Excellence in Medical Dermatology™
Excellence in Dermatopathology™

F035 - M&M for the Medical Dermatologist: Case-based Lessons

Friday, February 16; 3:30 PM - 5:30 PM

Learning Objectives

Following this course, the attendee should be able to:

  • Examine complications in the management of difficult problems in medical dermatology.
  • Identify potential sources of error in medical decision making in complex cases.
  • Discuss adverse outcomes in critically ill dermatology patients.

Description

Highly challenging cases in medical dermatology will be presented in the format of a Morbidity & Mortality conference. Emphasis will be placed on scenarios with the possibility of medical errors, adverse drug reactions and other complications. Cases will be presented in an interactive format to a panel of medical dermatology and dermatopathology experts, in a no-judgement environment in which these issues can be explored candidly.

Disclosures

  • Elston, Dirk Michael, MD: no financial relationships exist with commercial interests.
  • Fox, Lindy Peta, MD: no financial relationships exist with commercial interests.
  • Miller, Daniel D., MD: no financial relationships exist with commercial interests.
  • Rosenbach, Misha, MD: Derm101 – Independent Contractor(H); Endocyte – I(NC); Gilead Sciences, Inc – I(Grants/Research Funding); GlaxoSmithKline – C(NC); Merck & Co., Inc – A(H); Promet Therapeutics, LLC – C(H);
  • Shinkai, Kanade, MD, PhD: no financial relationships exist with commercial interests.
Schedule
Friday, February 16
3:30 PM
All faculty / Case Presentations and Panel Discussion
Event Details
  • Date
    Friday, February 16
  • Time
    3:30 PM - 5:30 PM
  • Location
    Room 6B
  • CME Credits
    2.00
  • Type
Directors/Co-Directors
  • Daniel D. Miller, MD, FAAD
Speakers
  • Dirk Michael Elston, MD, FAAD
  • Kanade Shinkai, MD, PhD, FAAD
  • Lindy Peta Fox, MD, FAAD
  • Misha Rosenbach, MD, FAAD